Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Xenome Ltd.

http://www.xenome.com

Latest From Xenome Ltd.

Questcor Pharmaceuticals appoints senior VP

Questcor Pharmaceuticals, which develops treatments for autoimmune and inflammatory disorders, has named Michael Aldridge senior vice-president, corporate strategic development. Prior to joining California, US-based Questcor, Mr Aldridge served as chief executive officer, managing director and board member of Australian biopharma, Xenome. He will report to Questcor’s chief operating officer, Steve Cartt.

Recent Financings of Private Companies (02/2012)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.

BioPharmaceutical Medical Device

2011 Scrip Asia 100 - Asia life science-focused VC firms

Asia life science-focused VC firms*

Taiwan

Recent Financings of Private Companies (06/2010)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
UsernamePublicRestriction

Register